Trial Profile
A Phase 1, Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TD-0714 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs TD 0714 (Primary)
- Indications Cardiovascular disorders; Kidney disorders
- Focus Adverse reactions; First in man
- Sponsors Theravance Biopharma
- 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association
- 09 Mar 2016 Results from this trial were published in a Theravance Biopharma media release.
- 09 Mar 2016 According to Theravance media release, top-line results are expected in the second half of 2016.